MORE INFORMATION
FOR INVESTORS

Resources



UltraGene® Combo2Screen SARS-CoV-2 Assay

ABLDx has submitted an EUA application to the FDA for clinical use of the UltraGene® Combo2Screen SARS-CoV-2 Assay as a test for COVID-19.

Links to more COVID-19 testing information

Registration Status

ABLDx has submitted an EUA application to the FDA for clinical use of the UltraGene® Combo2Screen SARS-CoV-2 Assay as a test for COVID-19.

Stay up to date on our response to COVID-19.

We'll send you updates on resources such as customer communications, fact sheets and testing information.